About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Borderline Resectable BTC: Case Presentations and Panel Discussions
By
Integrity CE
FEATURING
Mari Nakazawa
,
Chris Shubert
,
Mark Yarchoan
,
James Harding
By
Integrity CE
FEATURING
Mari Nakazawa
,
Chris Shubert
,
Mark Yarchoan
,
James Harding
114 views
March 27, 2024
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
27:04
Fengting Yan
Cancer Screening Molecular Tools
22:55
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…
Feat.
R. Kim,
R. Mehta
29:25
Northwestern Medicine Oncology and Hematology
Hyperprogression in Cancer Treated With Immunotherapy
Feat.
Y. Chae
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
22:33
Integrity CE
Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…
Feat.
V. Lee,
R. Kumar,
N. Bhagat,
E. Winslow
06:47
UCSF School of Medicine
Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…
Feat.
H. Kang
28:25
Integrity CE
Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…
Feat.
V. Lee,
E. Christenson,
N. Bhagat,
E. Winslow
07:27
Jason Levy
Opus One: Final Results - RFA in Axial Skeleton
16:40
Moffitt Cancer Center
Year in Review: Hepatobiliary Cancers
Feat.
R. Kim,
T. Biachi
13:47
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…
Feat.
V. Subbiah
06:03
Total Health
2024 Updates on Targeted Approaches for GI Cancers and New Data in N…
Feat.
A. Grothey
09:03
Integrity CE
Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management
Feat.
J. Birkness-Gartman
09:13
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary C…
Feat.
N. Uboha,
K. Spencer,
M. Cecchini
08:24
Yale Cancer Center
GI Oncology Year in Review: Hepatobiliary Cancers
Feat.
P. Kunz
12:04
Arndt Vogel
Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions
15:24
Horizon CME
MRD in GI Malignancies: Current Clinical Utility of ctDNA
Feat.
A. Scott
14:54
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highl…
Feat.
L. Rimassa
14:33
Insights from 2023 ESMO Annual Meeting
Personalized Medicine and Targeted Agents for Biliary Tract Cancer
Feat.
L. Rimassa
